SEARCH
2011 NEWS ARCHIVE
December 2, 2011
Morphotek Terminates Farletuzumab Study (FAR 122) in Platinum-Resistant Ovarian Cancer
June 28, 2011
Morphotek, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
June 27, 2011
Morphotek, Inc. Employees Collect Nearly 9,000 Pounds of Food For Local Families
April 27, 2011
Precis Engineering Provides MEP Engineering, Commissioning for Morphotek Pilot Plant
April 12, 2011
Morphotek Receives Grant to Support Development of Therapeutic Antibodies Against Biowarfare Agents
April 6, 2011
Morphotek, Inc. Receives Beacon Award From CancerCare
April 4, 2011
Morphotek, Inc. Announces Acquisition of Tumor Targeting Assets from Transmolecular, Inc.
March 29, 2011
Morphotek, Inc. Announces an Agreement With Biocare Medical, LLC to Develop and Commercialize A Diagnostic Kit For Detection of Folate Receptor Alpha in Malignant Tissues
Back to Entire News Archive